Muller AG Cleaning Solutions Appoints Dr Christian Heuer As New Managing Director - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Muller AG Cleaning Solutions Appoints Dr Christian Heuer As New Managing Director


The Müller Group, a supplier of packaging, product handling, and cleaning systems mainly for pharmaceutical production, announced that it has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions. Long-standing managing director, Ruedi Peterhans, will focus on marketing and sales.

Heuer will be responsible for further developing the Systems/Handling/Cleaning business unit for pharmaceutical, cosmetic and food industry. With a chemical engineering doctorate from the Technical University of Berlin, Heuer brings on board his long-term international experience in the pharmaceutical market, particularly in cleaning and sterilization technology. He was previously responsible for global sales and marketing at the Belimed Group.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here